Merck Chalks Up 2nd Fosamax Trial Win In NJ
Jo Ann Sessner's case claiming Fosamax caused her osteonecrosis of the jaw, or jaw deterioration, was one of thousands of cases including similar allegations over the drug.
"We believe the evidence showed the company acted properly, and that Fosamax did not cause the plaintiff's dental and jaw problems," said Christy Jones of Butler Snow...
Already a subscriber? Click here to login